A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation

@article{Falutz2005APD,
  title={A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation},
  author={J. Falutz and S. Allas and D. Kotler and Melanie Thompson and P. Koutkia and J. Albu and B. Trottier and J. Routy and P. Cote and T. Abribat and S. Grinspoon},
  journal={AIDS},
  year={2005},
  volume={19},
  pages={1279–1287}
}
Objective:To investigate the effects of TH9507, a novel growth hormone releasing factor, on abdominal fat accumulation, metabolic and safety parameters in HIV-infected patients with central fat accumulation. Design and methods:Randomized, double-blind, placebo-controlled trial enrolling 61 HIV-infected patients with increased waist circumference and waist-to-hip ratio. Participants were randomized to placebo or 1 or 2 mg TH9507 subcutaneously, once daily for 12 weeks. The primary outcome was… Expand
73 Citations
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
  • 161
  • PDF
Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.
  • 72
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
  • 126
  • PDF
Effects of growth hormone-releasing hormone on bone turnover in human immunodeficiency virus-infected men with fat accumulation.
  • 21
  • PDF
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.
  • 122
Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection.
  • 110
Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients
  • 101
Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
  • 84
  • PDF
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
  • 372
  • PDF
...
1
2
3
4
...